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INTRODUCTION:  Patients  with  type 1 Gaucher  disease  have  been  reported  to  be  more  likely  to have
cholelithiasis.
PRESENTATION  OF CASE:  A case  of cholelithiasis  in  a patient  with  type  1 Gaucher  disease;  which  is very
intriguing  to show  this  comorbidity.  The  case  was  the only  known  case  with  this  pathology  in  time  of
diagnosis  in  our  country  (Kosovo).  The  patient  is  a 21-year  old  girl  a known  case  of type  1 Gaucher  disease,
at  the  age  of  8 years.  The  patient  underwent  elective  laparoscopic  cholecystectomy.  Chronic  inﬂammatory
changes  and  adhesions  were  obvious  during  surgery.ype 1 Gaucher disease
osovo
DISCUSSION:  Type  1  Gaucher  disease  patients  have  several  risk  factors  for gallstone  formation:  increased
biliary  excretion  of  glucosylceramide,  advanced  liver  disease  and  cirrhosis,  splenomegaly,  inborn  error
of metabolism,  chronic  systemic  inﬂammation,  T cell  dysfunction,  and  insulin  resistance”  to  risk  factors.
CONCLUSION:  Gallstones  and  cholecystitis  should  be  considered  when  abdominal  symptoms  and  liver
dysfunctions  are  seen  in  these  patients.  More  studies  are  needed  in especially  Kosovo.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Gaucher disease is a lipidosis caused by a deﬁciency of gluco-
erebrosidase that results in accumulation of glucocerebroside in
ells of the reticular-endothelial system [1]. This disease is man-
fested with wide spectrum of symptoms, hepatosplenomegaly,
nemia, thrombocytopenia, and bone abnormalities. Enzyme
eplacement therapy with modiﬁed glucocerebrosidase which tar-
ets macrophages has been established as a treatment for type 1
aucher disease [3]. Patients with type 1 Gaucher disease have been
eported to be more likely to have cholelithiasis [4–6]. We  report
 case of cholelithiasis in a patient with type 1 Gaucher disease;
hich is very intriguing to show this comorbidity. The case was
he only known case with this pathology in time of diagnosis in our
ountry (Kosovo).
. Presentation of case
Patient was a 21-year old girl with the diagnosis of type 1
aucher disease, at the age of 8 years on neurological symptoms
asis and a lysosomal enzyme activity assay with skin ﬁbroblasts.
amily history about this disease was negative. Patient is treated
ith therapy of Cerezyme 400 units × 4 = 1600 UI, every 2 weeks,
nd it started three month after diagnose of Gaucher disease was
etermined. At the beginning patient’s symptoms were like skin
∗ Corresponding author.
E-mail address: naimfanaj@gmail.com (N. Fanaj).
ttp://dx.doi.org/10.1016/j.ijscr.2016.11.008
210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
changes after injures, nose bleeding, high temperature and overall
fatigue and during the ultrasonography hepatosplenomegaly was
identiﬁed which was improved after ERT (Enzyme Replacement
Therapy) was started. One week before the surgery patient was
admitted in pediatric ward to receive the therapy according to the
protocols and treatment decided during the treatment in Germany.
As patient was  complaining of right upper abdominal pain follow-
ing fatty meals, which radiates to the back and frequent vomiting,
abdominal ultrasonography was arranged for, this showed multi-
ple gall stones with signs of cholecystitis, surgeon advice was  to
operate (Fig. 1).
The patient went under elective laparoscopic cholecystectomy.
During the intraoperative course it was found cholecystis with
atrophic chronic inﬂammatory changes and adhesions around
(Fig. 2). With succeeded procedures was performed the extrac-
tion of cholecystitis from the umbilical gate. In the fourth port
was placed drainage in the abdominal space. After one day con-
trol visits the patient was in good general condition, the wound
was quiet and without changes, abdominal drainage was  com-
pletely removed. (Uneventful laparoscopic cholecystectomy was
performed) The patient was discharged home with better local and
general condition, and recommending for visit after 72 h.
Pathology report conﬁrms the clinical diagnosis of chronic cal-
culus cholecystitis (Fig. 3).3. Discussion
Cholelithiasis is one of the most common gastrointestinal dis-
eases in adults but is rare in children. Children who have hemolytic
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Ultrasonography of the gallbladder showing gallstones.
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It was  obtained from the patient for publication of this caseFig. 2. Intra-operative view of ductus cysticus.
nemia or cholecystitis (due to infection with bacteria, viruses,
r parasites) or receiving long-term hyper alimentation have an
ncreased risk of gallstones [7].
The high incidence of gallstones in patients with Gaucher dis-
ase has been attributed to the high frequency of routine abdominal
maging, which would increase the likelihood that gallstones would
e found. However, a cohort study has demonstrated that the
Fig. 3. Histopathology view ofPEN  ACCESS
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prevalence of cholesterol gallstone disease is more than ﬁve times
higher in patients with type 1 Gaucher disease than to the general
population [6].
Type 1 Gaucher disease patients have several risk factors for
gallstone formation. First, increased biliary excretion of glucosyl-
ceramide predispose to gallstone formation. During the hepatic
secretion of bile salts and phospholipids decreases, the bile is
lithogenic [8]. Second, advanced liver disease and cirrhosis also
contribute to gallstone [9]. The high degree of liver involve-
ment is signiﬁcantly related to a higher risk of gallstones. Third,
splenomegaly, present in the most patients with Gaucher disease,
is a cause of hemolysis, which increase the risk of gallstone forma-
tion [4], but according to an article published in Journal of inherited
metabolic disease, 2010 June; 33(3): 291–300., authors declared
that “Interestingly, asplenic patients also have higher rates of chole-
cystectomy for symptomatic gallstones than patients with intact
spleen (25% vs 11%, p = 0.002)” [10].
In the present case, the patient tells that none of family mem-
bers has any genetically disease. The patient’s condition was good
with ERT, and she had neither hepatosplenomegaly nor hemolysis
without therapy. Furthermore, liver biopsy did not show cirrho-
sis. These ﬁndings suggest that the cause of gallstone formation in
this case was  increased biliary excretion of glucosylceramide, as
mentioned by Pentchev et al. [7].
4. Conclusion
Cholelithiasisis must be considered as a differential diagnosis in
a patient with abdominal pain and abnormal liver enzymes if he/she
is a known case of Gaucher disease type 1. Laparoscopic cholecys-
tectomy is safe and fruitful therapeutic procedure if gallstones are
conﬁrmed by ultrasound. More studies are needed to determine the
incidence and prevalence of gallstones in Gaucher disease patients
in especially Kosovo.
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